CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
Search for:
PPAR73 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C00074 | BRD-K79437791 | acetyl-farnesyl-cysteine | PPARG | methyltransferase inhibitor | Details | |
C00585 | BRD-A16694057 | BADGE | PPARG | PPAR receptor antagonist | Details | |
C00591 | BRD-A00147595 | balaglitazone | PPARG | insulin sensitizer; PPAR receptor partial agonist | Details | |
C00595 | BRD-K41410256 | balsalazide | ALOX5|PPARG|PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C00602 | BRD-K20545304 | bardoxolone | NOS2|PPARG | nuclear factor erythroid derived; like (NRF2) activator | Details | |
C00603 | BRD-K69694239 | bardoxolone-methyl | PPARG|STAT3 | nuclear factor erythroid derived; like (NRF2) activator | Details | |
C00721 | BRD-K46018455 | bezafibrate | PPARA|PPARD|PPARG | PPAR receptor agonist | Details | |
C00767 | BRD-K41494493 | bisphenol-a | AR|ESR1|ESR2|ESRRG|PPARG | synthetic estrogen | Details | |
C01125 | BRD-K86954340 | cetaben | PPARA | cholesterol inhibitor; ACAT inhibitor | Details | |
C01247 | BRD-A93000692 | ciglitazone | PPARG | PPAR receptor agonist | Details | |
C01275 | BRD-K24570280 | CINPA-1 | NR1H4|NR1I3|PPARG | CAR antagonist | Details | |
C01279 | BRD-A49358627 | ciprofibrate | PPARA | PPAR receptor agonist | Details | |
C01331 | BRD-K45252063 | clofibrate | LPL|PPARA | PPAR receptor agonist | Details | |
C01332 | BRD-K19111024 | clofibric-acid | PPARA | PPAR receptor agonist | Details | |
C01407 | BRD-K96843359 | CP-775146 | PPARA | PPAR receptor agonist | Details | |
C01553 | BRD-K82908348 | darglitazone | PPARG | PPAR receptor antagonist | Details | |
C01588 | BRD-K41256143 | dehydroepiandrosterone | ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1 | protein synthesis stimulant | Details | |
C01640 | BRD-K75748943 | DG-172 | PPARD | PPAR receptor inverse agonist | Details | |
C01662 | BRD-K08252256 | diclofenac | AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A | cyclooxygenase inhibitor | Details | |
C01767 | BRD-K39965020 | doconexent | FFAR1|PTGS1|PTGS2 | PPAR receptor agonist | Details | |
C01850 | BRD-A25182582 | edaglitazone | PPARG | PPAR receptor agonist | Details | |
C01861 | BRD-A24560335 | efatutazone | PPARG | PPAR receptor agonist | Details | |
C01876 | BRD-K03165895 | elafibranor | PPARA|PPARD | PPAR receptor agonist | Details | |
C01912 | BRD-A11776908 | enilconazole | CYP19A1|CYP1A2|CYP2B6|CYP2C9|CYP2J2|CYP3A4|CYP3A5|NR1I2|PPARA|PTGER2 | sterol demethylase inhibitor | Details | |
C02049 | BRD-K49338325 | etofibrate | PPARA | PPAR receptor agonist | Details | |
C02051 | BRD-K49840922 | etofylline-clofibrate | PPARA | platelet aggregation inhibitor | Details | |
C02121 | BRD-K50388907 | fenofibrate | MMP25|PPARA | PPAR receptor agonist | Details | |
C02122 | BRD-K30213273 | fenofibric-acid | CLCN1|PPARA | cytochrome P450 inhibitor | Details | |
C02145 | BRD-K48112880 | FH-535 | PPARD|PPARG | PPAR receptor antagonist; WNT signaling inhibitor | Details | |
C02224 | BRD-K15327298 | fmoc-l-leucine | PPAR receptor agonist | Details | ||
C02293 | BRD-K77345217 | gallic-acid | CA1|CA12|CA14|CA2|CA4|CA6|CA9|SELP | beta amyloid protein neurotoxicity inhibitor; PPAR receptor agonist | Details | |
C02328 | BRD-K11129031 | gemfibrozil | LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1 | lipoprotein lipase activator | Details | |
C02333 | BRD-K43797669 | genistein | CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5 | tyrosine kinase inhibitor | Details | |
C02362 | BRD-K12219985 | glipizide | ABCC8|KCNJ10|KCNJ11|PPARG | sulfonylurea | Details | |
C02422 | BRD-K98684188 | GSK-0660 | PPARD | PPAR receptor antagonist | Details | |
C02452 | BRD-K03155172 | GSK3787 | PPARD | PPAR receptor antagonist | Details | |
C02475 | BRD-K82983861 | GW-0742 | PPARD | PPAR receptor agonist | Details | |
C02477 | BRD-A15415227 | GW-1929 | PPARG | PPAR receptor agonist | Details | |
C02485 | BRD-K14880289 | GW-501516 | PPARA|PPARD | PPAR receptor agonist | Details | |
C02490 | BRD-K20828910 | GW-6471 | PPARA | PPAR receptor antagonist | Details | |
C02491 | BRD-K96263742 | GW-7647 | PPARA | PPAR receptor agonist | Details | |
C02497 | BRD-K93258693 | GW-9662 | NCOA2|PPARG|RXRA | PPAR receptor antagonist | Details | |
C02529 | BRD-K15231341 | hemomex-s | PPARG | Details | ||
C02619 | BRD-K14965640 | ibuprofen-(s) | ASIC1|BCL2|CFTR|FABP2|PLAT|PPARG|PTGS1|PTGS2|SLC5A8|THBD | cyclooxygenase inhibitor | Details | |
C02629 | BRD-K24476327 | icaritin | PDE5A | PPAR receptor antagonist | Details | |
C02642 | BRD-K47192521 | icosapent | ACSL3|ACSL4|FADS1|FFAR1|PPARD|PPARG|PTGS1|PTGS2|SLC8A1|TRPV1 | platelet aggregation inhibitor | Details | |
C02711 | BRD-K57222227 | indomethacin | GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1 | cyclooxygenase inhibitor | Details | |
C02943 | BRD-K98372770 | L-165041 | PPARD | PPAR receptor agonist | Details | |
C03069 | BRD-K08973992 | linoleic-acid | FABP4|FFAR1|FFAR4|HNF4A|KCNB1|PPARG|TRPM8 | oxidative stress inducer | Details | |
C03207 | BRD-K26168087 | magnolol | GABRA1|PPARG | PPAR receptor agonist | Details | |
C03244 | BRD-K24283677 | ME-0328 | PARP3 | PPAR receptor antagonist | Details | |
C03313 | BRD-K28849549 | mesalazine | ALOX5|CHUK|IKBKB|MPO|PPARG|PTGS1|PTGS2 | cyclooxygenase inhibitor; lipoxygenase inhibitor; prostanoid receptor antagonist | Details | |
C03412 | BRD-A72066420 | mifobate | PPARG | PPAR receptor antagonist | Details | |
C03434 | BRD-K52959329 | mitiglinide | ABCC8|KCNJ10|PPARG | insulin secretagogue | Details | |
C03631 | BRD-K44353683 | nateglinide | ABCC8|KCNJ10|KCNJ11|PPARG | insulin secretagogue | Details | |
C03773 | BRD-K65275554 | NPC-15199 | PPARG | ICAM1 antagonist | Details | |
C03805 | BRD-K54708045 | nTZDpa | PPARG | PPAR receptor agonist | Details | |
C03871 | BRD-K66956375 | oleoylethanolamide | CNR1|GPR119|GPR55|PPARA | cannabinoid receptor agonist; glucose dependent insulinotropic receptor agonist; potassium channel blocker; PPAR receptor agonist | Details | |
C04264 | BRD-A48430263 | pioglitazone | PPARG|TRPM3 | insulin sensitizer; PPAR receptor agonist | Details | |
C04288 | BRD-K01902415 | pirinixic-acid | PPARA | PPAR receptor agonist | Details | |
C04467 | BRD-K53097745 | pterostilbene | PTGS2 | cyclooxygenase inhibitor; PPAR receptor agonist | Details | |
C04571 | BRD-K82846253 | repaglinide | ABCC8|KCNJ11|PPARG | insulin secretagogue | Details | |
C04686 | BRD-A97437073 | rosiglitazone | ACSL4|FFAR1|PPARG|TRPC5|TRPM3 | insulin sensitizer; PPAR receptor agonist | Details | |
C04786 | BRD-K79878800 | saroglitazar | PPARA|PPARG | PPAR receptor agonist | Details | |
C05051 | BRD-K62814487 | SR-1664 | PPARG | PPAR receptor ligand | Details | |
C05131 | BRD-K10670311 | sulfasalazine | ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1 | cyclooxygenase inhibitor | Details | |
C05136 | BRD-A13946108 | sulindac | AKR1B1|MAPK3|PPARD|PTGDR2|PTGS1|PTGS2 | cyclooxygenase inhibitor | Details | |
C05166 | BRD-K48826825 | S26948 | PPARG | PPAR receptor agonist | Details | |
C05168 | BRD-K31843556 | T-0070907 | PPARG | PPAR receptor antagonist | Details | |
C05303 | BRD-K73999723 | telmisartan | AGTR1|PPARG | angiotensin receptor antagonist | Details | |
C05343 | BRD-K15507868 | tesaglitazar | PPARA|PPARG | insulin sensitizer; PPAR receptor agonist | Details | |
C05535 | BRD-K71879491 | tretinoin | ALDH1A1|ALDH1A2|GPRC5A|NR0B1|NR2C2|PPARD|RARA|RARB|RARG|RARRES1|RORB|RORC|RXRB|RXRG | retinoid receptor agonist; retinoid receptor ligand | Details | |
C05584 | BRD-A13084692 | troglitazone | ACSL4|ESRRA|ESRRG|PPARG|SERPINE1|SLC29A1|TRPM3 | insulin sensitizer; PPAR receptor agonist | Details |